<iframe src="//www.googletagmanager.com/ns.html?id=GTM-WSMCRCP" height="0" width="0" style="display:none;visibility:hidden">

Audio commentary: An update on COVID-19 and the race to develop a vaccine

Aug 20, 2020 | RBC Wealth Management


Share

Dr. MacKay updates us on the data on COVID-19 cases and how close we are to a vaccine. He answers the question: “When will we be back to normal?”

Audio commentary: An update on COVID-19 and the race to develop a vaccine

Dr. Kennen MacKay, Managing Director and Co-Head of Biotechnology Research for RBC Capital Markets, joins Janet Engels, Head of the Portfolio Advisory Group – U.S., to talk about where things stand with COVID-19. They zero in on the data on the number of cases, and discuss how close we are to a vaccine as well as the impact of the race to find effective treatments, now and in the future. Janet asks the question on all our minds: “When will we be back to normal?”

Listen to audio (20:38 duration)

Categories

Analysis